Allico Pharmaceutical, 10 Billion KRW Convertible Bonds... Factory Expansion Funds

[Asia Economy Reporter Hyungsoo Park] Allico Pharmaceutical, a specialty pharmaceutical manufacturer, announced on the 13th that it will privately issue convertible bonds worth 10 billion KRW to expand its factory.

The bond maturity interest rate is 1.0%, and the coupon rate is 0.0%. The conversion price is 7,802 KRW, and the maturity date of the convertible bonds is February 18, 2025. The number of shares to be issued upon conversion is 1,281,722 shares (8.36%).

The raised funds will be used to expand the Jincheon factory, a pharmaceutical production plant. A company official explained, "After the expansion, we plan to enlarge research facilities and packaging lines and establish a large-scale production line."

Allico Pharmaceutical is a specialty pharmaceutical manufacturer listed on the KOSDAQ market in 2018. It has secured sales stability centered on ETC and is preparing to expand market dominance through new businesses in medical devices and women’s health management.

This content was produced with the assistance of AI translation services.